Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 714.47 -0.66 (-0.09%) Market Cap: 78.51 Bil Enterprise Value: 71.42 Bil PE Ratio: 17.68 PB Ratio: 2.68 GF Score: 88/100

Regeneron Pharmaceuticals Inc Investor Webcast Transcript

Dec 14, 2022 / 01:30PM GMT
Release Date Price: $750 (+0.33%)
Operator

Welcome to the Regeneron Pharmaceuticals ASH 2022 Investor Conference Call. My name is Catherine, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the call over to Ryan Crowe, Vice President of Investor Relations. You may begin.

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

Thank you, Catherine. Good morning, good afternoon and good evening to everyone listening around the globe. Welcome to our ASH 2022 Investor Call. Slides for our presentation have been posted to the Investors section of the regeneron.com website.

I would like to remind you that today's remarks include forward-looking statements about Regeneron's business and research and development programs, anticipated milestones and regulatory matters. Each forward-looking statement is subject to risks and uncertainties that could cause the actual results and events to differ materially from those projected in that statement. A more complete description of these and other material risks can be found

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot